Home
Conditions
Urologic Diseases

Clinical trial condition

Urologic Diseases

Explore clinical trials studying Urologic Diseases. Study availability and eligibility vary by location and protocol.

13,759 public trials 2,168 recruiting studies

Refine in advanced search Browse all conditions

Urologic Diseases trial results

Completed

A Study to Evaluate the Pharmacokinetics, Safety, and Pharmacodynamics of Olpasiran in Participants With Normal Renal Function and Participants With Various Degrees of Renal Impairment

NCT05489614

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Kidney Diseases, +5 more
Locations: Inland Empire Clinical Trials, LLC Rialto, California, United States

CRSCA HC LLC, dba Creekside Post Acute Yucaipa, California, United States

Clinical Pharmacology Of Miami, LLC Miami, Florida, United States

Advanced Pharma CR, LLC Miami, Florida, United States

View Trial Details

Completed

Alport Syndrome Treatments and Outcomes Registry

NCT00481130

Conditions: Alport Syndrome, Alport syndrome, dominant type, Collagen Diseases, +13 more
Locations: University of Minnesota Minneapolis, Minnesota, United States

View Trial Details

Completed

Efficacy and Mechanism of High-Dose Vitamin D Supplementation in Pediatric OAB-Dry: A Randomized Clinical Trial Integrating Urinary Myelin Basic Protein as a Theranostic Biomarker

NCT06489951

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +10 more
Locations: Children's Hospital of Chongqing Medical University Chongqing, Chongqing Municipality, China

View Trial Details

Completed

Evaluation of Sevoflurane Consumption During Initial Phase of Minimal-Flow Anesthesia in Retrograde Intrarenal Surgery

NCT07248917

Conditions: Actinomycetales Infections, Anesthesia Depth Monitoring, Anesthetic Consumption, +17 more
Locations: Kartal Dr. Lütfi Kırdar City Hospital, University of Health Sciences Istanbul, Turkey (Türkiye)

View Trial Details

Completed

A Phase 1b Study to Assess the Safety, Tolerability, and Pharmacodynamics of AZD4144 in Participants With Established Atherosclerotic Cardiovascular and Chronic Kidney Disease.

NCT06675175

Conditions: Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +16 more
Locations: Research Site Glendale, California, United States

Research Site Daytona Beach, Florida, United States

Research Site Jacksonville, Florida, United States

Research Site Miami, Florida, United States

View all 15 locations

View Trial Details

Completed

Continuous Erector Spinae Plane Blocks to Treat Pain Following Percutaneous Nephrolithotomy

NCT05121168

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Kidney Diseases, +14 more
Locations: UC San Diego San Diego, California, United States

University of California, San Diego San Diego, California, United States

View Trial Details

Completed

The Impact of Post-operative Voiding Trial on Length of Stay Following Laparoscopic Hysterectomy: A Prospective, Randomized Control Trial

NCT04487600

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Hysterectomy, +6 more
Locations: Not specified

View Trial Details

Completed

Effect of Preoperative Alpha-blockers on Successful Insertion Ureteral Access Sheath and Reduce Ureteral Injury in Non-prestented Patients During RIRS. Assessment of Factors for Successful Ureteral Access Sheath Insertion.

NCT07202923

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +6 more
Locations: St. Luke's Clinical Hospital Saint Petersburg, Outside U.S./Canada, Russia

View Trial Details

Completed

Impact of Mortality Salience on Treatment Decisions

NCT06545188

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +8 more
Locations: University Hospital Düsseldorf, Department of Urology Düsseldorf, Germany

View Trial Details

Completed

Study of Pembrolizumab (MK-3475) and Pembrolizumab With Other Investigational Agents in Participants With High Risk Non-muscle Invasive Bladder Cancer (MK-3475-057/KEYNOTE-057)

NCT02625961

Conditions: Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations: Not specified

View Trial Details

Urologic Diseases

Urologic Diseases trial results

Related conditions